| Study type |
n |
Outcomes |
References |
| Retrospective cohort study, mean 1.9 months follow-up |
634, 49 % had at least 3 risk factors |
CIED implantation was successful in 99.5 % of procedures. Major infections rate 0.48 after 1.9 ± 2.4 months follow-up. |
51 |
| Retrospective cohort study, min 90 days follow-up 260, |
mean 2.8 ± 1.2 risk factors |
One CIED infection among patients who received an antibacterial envelope (0.4 %), compared with 19 (3 %) in controls (odds ratio [95 % CI] 0.13 [0.02–0.95]; p=0.04. |
52 |
| Observational cohort study, consecutive patients |
2,891 |
In the pre-envelope era, an infection occurred in 25 (1.5 %) of 1,651 patients. After its availability, an envelope was used in 275 (22 %) of 1,240 patients; an infection occurred in 8 (0.6 %) patients in this era (p=0.029 vs pre-envelope). |
43 |
| Prospective, observational multicentre cohort study, interim 180 day data available |
1,000 |
Infection occurred in 0.2 % of patients who received the envelope compared with 1.9 % who did not receive the envelope (p <0.001). |
55 |
